je.st
news
Philadelphia biotech firm gets $3.5M NIH contract to study Ebola, hepatits C viruses
2014-11-15 12:08:06| Biotech - Topix.net
The National Institutes of Health awarded Integral Molecular Inc. a five-year, $3.5 million contract to study the human immune response to the Ebola virus and hepatitis C virus. The funding will enable the Philadelphia biotechnology company to better understand how human antibodies protect, or fail to protect, people against such viruses.
Tags: study
firm
contract
philadelphia
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||